Get the Stockscreener App
10.49
1.32%
-0.14
Core Laboratories Inc stock is traded at $10.49, with a volume of 617.13K.
It is down -1.32% in the last 24 hours and down -12.95% over the past month.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
See More
Previous Close:
$10.63
Open:
$10.76
24h Volume:
617.13K
Relative Volume:
0.80
Market Cap:
$481.33M
Revenue:
$524.73M
Net Income/Loss:
$31.70M
P/E Ratio:
15.85
EPS:
0.6617
Net Cash Flow:
$22.47M
1W Performance:
-7.98%
1M Performance:
-12.95%
6M Performance:
-33.23%
1Y Performance:
-16.01%
1-Day Range:
$10.45
$10.82
1-Week Range:
$10.45
$11.65
52-Week Range:
$9.79
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Name
Core Laboratories Inc
Sector
Industry
Phone
713-328-2673
Address
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, TS, FTI, HAL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
10.49 | 481.33M | 524.73M | 31.70M | 22.47M | 0.6617 |
SLB
Slb Ltd
|
51.43 | 76.32B | 35.91B | 3.38B | 4.41B | 2.2806 |
BKR
Baker Hughes Company
|
57.29 | 56.87B | 27.89B | 3.15B | 2.29B | 3.1363 |
TS
Tenaris Sa Adr
|
55.88 | 28.21B | 12.19B | 2.03B | 1.87B | 3.8072 |
FTI
Technipfmc Plc
|
70.95 | 27.82B | 10.17B | 1.08B | 1.34B | 2.6138 |
HAL
Halliburton Co
|
32.76 | 27.29B | 22.37B | 1.61B | 1.73B | 1.9091 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-25 | Upgrade | Citigroup | Sell → Neutral |
| Jun-30-23 | Downgrade | Citigroup | Neutral → Sell |
| Apr-18-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-09-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-07-22 | Upgrade | Citigroup | Sell → Neutral |
| Sep-26-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Apr-18-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Oct-18-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-09-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-14-21 | Downgrade | Citigroup | Neutral → Sell |
| Dec-18-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-11-20 | Reiterated | Cowen | Market Perform |
| Oct-13-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Sep-29-20 | Upgrade | ABN Amro | Sell → Hold |
| Jul-16-20 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Apr-13-20 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Mar-09-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Mar-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-31-20 | Reiterated | Cowen | Market Perform |
| Jan-30-20 | Resumed | Johnson Rice | Buy |
| Jan-14-20 | Initiated | Bernstein | Mkt Perform |
| Jan-02-20 | Downgrade | Stifel | Buy → Hold |
| Dec-31-19 | Reiterated | Cowen | Market Perform |
| Jul-10-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-25-19 | Upgrade | Tudor Pickering | Hold → Buy |
| Dec-19-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-11-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-16-18 | Upgrade | Guggenheim | Neutral → Buy |
| Nov-01-18 | Upgrade | ABN Amro | Sell → Buy |
| Oct-29-18 | Reiterated | Cowen | Market Perform |
View All
Core Laboratories Inc Stock (CLB) Latest News
CLB Declines 35% in the Past Six Months: How to Play the Stock? - finance.yahoo.com
Top 3 Energy Stocks You'll Regret Missing In September - webull.com
Top Core Laboratories (CLB) Competitors 2026 - MarketBeat
Zacks Research Cuts Earnings Estimates for Core Laboratories - MarketBeat
LBRT Stock Soars 79% in a Year: Should Investors Wait or Move On? - TradingView
Zacks Research Expects Weaker Earnings for Core Laboratories - MarketBeat
Legal & General Group Plc Buys Shares of 122,575 Core Laboratories Inc. $CLB - MarketBeat
Bank of New York Mellon Corp Makes New Investment in Core Laboratories Inc. $CLB - MarketBeat
CLB News | CORE LABORATORIES INC (NYSE:CLB) - ChartMill
Zacks Industry Outlook Highlights TechnipFMC, Oceaneering International, Inc. and Core Laboratories - Eastern Progress
Core Porosity Analyzers Market - Future Market Insights
3 Oilfield Services Stocks Poised to Gain Despite Industry Challenges - TradingView
BlackRock Inc. Makes New Investment in Core Laboratories Inc. $CLB - MarketBeat
Bank of America Corp DE Has $3.77 Million Position in Core Laboratories Inc. $CLB - MarketBeat
BofA Securities Maintains Core Laboratories(CLB.US) With Sell Rating, Maintains Target Price $11 - Moomoo
Core Laboratories NV (CLB) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
Kwaku Temeng to Resign from Core Laboratories Board, Effective Oct 1, 2026 - TradingView
Core (CLB) Quarter in Focus: Profit Per Share Clears Its Benchmark in the Latest Session - vinanet.vn
Gulfport Energy and Mobility Global Set to Join S&P SmallCap 600 - easternprogress.com
Q4 EPS Forecast for Core Laboratories Lifted by Analyst - MarketBeat
John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF Value - GuruFocus
101,648 Shares in Core Laboratories Inc. $CLB Purchased by Rice Hall James & Associates LLC - MarketBeat
CLB Q2 2026 Earnings: EPS Beats by 25.1% as Operational Execution Drives ResultsFinancial Summary - vinanet.vn
Renaissance Technologies LLC Sells 132,797 Shares of Core Laboratories Inc. $CLB - MarketBeat
Core Laboratories (CLB) Holds Above $12.40 as Oilfield Services Sector StabilizesTriple Top - vinanet.vn
Disciplined Growth Investors (CLB) reports 6.6% Core Laboratories stake on Schedule 13G/A - Stock Titan
Ariel Investments (CLB) discloses 30.5% Core Laboratories stake in Schedule 13G/A - Stock Titan
Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice - MarketBeat
Core Laboratories Inc. (CLB) stock price, news, quote and history - Yahoo Finance Australia
Core Laboratories (CLB) Edges Lower to $12.38 as Energy Sector Headwinds PersistFactor Rotation - dars.gov.et
Core Laboratories Inc. (HJ1.F) stock price, news, quote and history - Yahoo Finance UK
CLB Q2 2026 Earnings: EPS Beats Estimates by 25.14%, Delivering a Notable Upside SurpriseDividend Growth Analysis - careplusvn.com
CLB Q2 2026 Earnings: EPS Beats Estimates by 25% on Operational StrengthROIC Trend Report - careplusvn.com
Core Laboratories N.V. (CLB) stock price, news, quote and history - Yahoo Finance UK
Core Laboratories Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
Core Laboratories' (NYSE:CLB) Weak Earnings May Only Reveal A Part Of The Whole Picture - webull.com
Core Laboratories (CLB) Q2 2026 Earnings Call Transcript - The Globe and Mail
Core Laboratories Inc (CLB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Dimensional Fund Advisors LP Increases Stock Position in Core Laboratories Inc. $CLB - MarketBeat
BlackRock (CLB holder) discloses 8.3% beneficial stake in Core Laboratories Inc - Stock Titan
Core Laboratories Inc (CLB) Chairman and CEO Lawrence Bruno Buys 5,000 Shares - GuruFocus
Core Laboratories (NYSE:CLB) CEO Lawrence Bruno Buys 5,000 Shares - MarketBeat
Core Laboratories (NYSE: CLB) CEO purchases 5,000 shares in open-market trade - Stock Titan
Core Laboratories CEO Lawrence Bruno Acquires 5,000 Shares in Open Market Transaction - Kalkine Media
CLB Q2 2026 Earnings: EPS Beats by 25.1% at $0.11, Shares Advance 2.8%Earnings Sentiment Score - vinanet.vn
Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results? - TradingView
Core Lab Q2 earnings miss analyst estimates By Investing.com - Investing.com Canada
Core Lab Q2 earnings miss analyst estimates - investing.com
Core Laboratories (CLB) Q2 Earnings Surpass Estimates - Yahoo Finance Singapore
Core Laboratories Inc reports results for the quarter ended June 30Earnings Summary - tradingview.com
Core Laboratories Inc Stock (CLB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):